Glycolysis in tumor cells as well as the downregulation of GLUT1 can limit T cell metabolism (51), which results in lower expression of mTOR, reduced expression of glycolysis-related genes, and decreased IFN-γ production, all of which contribute to the impairment of T cell’s antitumor abilities. The gene discussed is MTOR; the disease is neoplasm.